Drug Trials Snapshot: RUBRACA (rucaparib)

Drug Approvals 

DRUG TRIALS SNAPSHOT SUMMARY:

What is the drug for?

RUBRACA is a drug used to treat women with advanced ovarian cancer who:

• have certain BRCA gene mutation (either inherited or acquired), and
• have received previous treatment with 2 or more chemotherapy medicines for their cancer.

How is this drug used?

Two tablets (total of 600 mg) are taken two times a day with or without food.....